This paper describes the protocol for the REACH trial, a randomized controlled trial designed to evaluate the 12-month efficacy of tailored e-counselling in 528 patients with hypertension.
RCT (n=528)
Double-blind
two-parallel group
Sí
Does tailored e-counselling reduce blood pressure and improve adherence to self-management behaviors in adults with stage 1 or 2 hypertension?
This protocol outlines a randomized controlled trial to evaluate whether tailored e-counselling improves blood pressure and lifestyle adherence over 12 months in patients with hypertension.
INTRODUCTION: Web-based lifestyle counselling designed to improve adherence to self-management behaviours for diet, exercise and medication has been shown to reduce blood pressure (BP). However, the long-term clinical outcome of these interventions is not established. Our aim was to establish whether an e-counselling program is independently associated with improved clinical outcomes over a 12-month period, as defined by the following criteria: (1) reduction of systolic BP, diastolic BP, pulse pressure and associated risk factors for cardiovascular events; and (2) adherence to self-management behaviour (diet, exercise, smoke-free living and prescribed medication). METHODS AND ANALYSIS: Reducing risk with e-based support for adherence to lifestyle change in hypertension is a two-parallel group, double-blind randomised controlled trial that will utilise a two (Groups: e-counselling vs control) by three (assessment intervals: baseline, 4-month and 12-month outcome) design. BP, lipoprotein cholesterol, physical activity and dietary behaviours and psychological distress will be measured at each assessment. We plan to recruit 528 participants (35-74 years of age) diagnosed with stage 1 or 2 hypertension (systolic BP, 140-180 mm Hg; diastolic BP 90-110 mm Hg) from three major cities (Toronto, London, Vancouver) and one rural area (Grey Bruce region) across Canada between February 2012 and July 2015. Controls will receive general educational e-messages on heart healthy living and the e-counselling group will receive tailored e-messages that are matched to their stage of readiness for change. For both groups, e-messages will be sent proactively on a weekly basis during months 1-4, then bi-weekly during months 5-8 and then monthly during months 9-12. ETHICS AND DISSEMINATION: Ethical approval has been obtained from all recruitment sites. This will be one of the first studies to evaluate the long-term efficacy of preventive e-counselling strategies for cardiovascular disease prevention in patients with hypertension. Findings from this study will be used to guide the ongoing development of e-counselling services. TRIAL REGISTRATION: Clinicaltrial.gov NCT01541540; http://clinicaltrials.gov/ct2/show/NCT01541540.
Nolan et al. (Thu,) conducted a rct in stage 1 or 2 hypertension (n=528). Tailored e-counselling program vs. General educational e-messages was evaluated on Reduction of systolic BP, diastolic BP, pulse pressure, associated cardiovascular risk factors, and adherence to self-management behaviour. This paper describes the protocol for the REACH trial, a randomized controlled trial designed to evaluate the 12-month efficacy of tailored e-counselling in 528 patients with hypertension.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: